Literature DB >> 8553676

Multidisciplinary approach to the treatment of unresectable breast cancer.

Z Z Shen1, Y W Zhang, T X Pan, C J Xia.   

Abstract

Between January 1960 and December 1990, 163 patients with locally advanced breast cancer (LABC) were treated by multidisciplinary treatment regimens. Forty-six cases received preoperative intraarterial perfusion of cytotoxic drugs. Fifty-four cases received preoperative systemic chemotherapy. Forty-one cases received preoperative radiotherapy, and twenty-two cases received both radiotherapy and chemotherapy. Preoperative systemic chemotherapy gives the best results. Postoperative chemotherapy and radiotherapy did not improve the survival rate as compared to the control group. The authors suggest that preoperative induction chemotherapy be used for LABC patients.

Entities:  

Mesh：

Year:  1995        PMID： 8553676     DOI： 10.1007/bf00299781

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


  12 in total

Review 1.  Recent developments in the use of systemic adjuvant therapy for the treatment of breast cancer.

Authors:  B Fisher; D L Wickerham; C Redmond
Journal:  Semin Oncol       Date:  1992-06       Impact factor: 4.929

2.  RADICAL IRRADIATION OF ADVANCED BREAST CANCER.

Authors:  G H FLETCHER; E D MONTAGUE
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1965-03

Review 3.  Systemic treatment for locally advanced breast cancer: what we still need to learn after a decade of multimodality clinical trials.

Authors:  M J Piccart; J Kerger; E Tomiak; D J Perrault
Journal:  Eur J Cancer       Date:  1992       Impact factor: 9.162

Review 4.  Treatment of locally advanced breast cancer.

Authors:  D J Booser; G N Hortobagyi
Journal:  Semin Oncol       Date:  1992-06       Impact factor: 4.929

5.  CARCINOMA OF THE BREAST: II. CRITERIA OF OPERABILITY.

Authors:  C D Haagensen; A P Stout
Journal:  Ann Surg       Date:  1943-11       Impact factor: 12.969

6.  Treatment of stage III breast cancer. A panel discussion.

Authors:  W L McGuire; M D Abeloff; G N Hortobagyi; S M Swain
Journal:  Breast Cancer Res Treat       Date:  1989-07       Impact factor: 4.872

7.  Preoperative (neoadjuvant) chemotherapy for breast cancer: outline of the British Columbia Trial.

Authors:  J Ragaz
Journal:  Recent Results Cancer Res       Date:  1986

8.  Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer.

Authors:  S M Swain; R A Sorace; C S Bagley; D N Danforth; J Bader; M N Wesley; S M Steinberg; M E Lippman
Journal:  Cancer Res       Date:  1987-07-15       Impact factor: 12.701

Review 9.  Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy.

Authors:  G N Hortobagyi; F C Ames; A U Buzdar; S W Kau; M D McNeese; D Paulus; V Hug; F A Holmes; M M Romsdahl; G Fraschini
Journal:  Cancer       Date:  1988-12-15       Impact factor: 6.860

10.  Neoadjuvant intra-arterial chemotherapy in locally advanced breast cancer: a prospective randomized study. Osaka Breast Cancer Study Group.

Authors:  Y Takatsuka; E Yayoi; T Kobayashi; T Aikawa; Y Kotsuma
Journal:  Jpn J Clin Oncol       Date:  1994-02       Impact factor: 3.019
View more
  2 in total

1.  Skin involvement and breast cancer: are T4b lesions of all sizes created equal?

Authors:  Diana Silverman; Karen Ruth; Elin R Sigurdson; Brian L Egleston; Lori J Goldstein; Yu-Ning Wong; Marcia Boraas; Richard J Bleicher
Journal:  J Am Coll Surg       Date:  2014-04-20       Impact factor: 6.113

Review 2.  Hyperthermia for locally advanced breast cancer.

Authors:  Timothy M Zagar; James R Oleson; Zeljko Vujaskovic; Mark W Dewhirst; Oana I Craciunescu; Kimberly L Blackwell; Leonard R Prosnitz; Ellen L Jones
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.